Finance

Lists
Why is ANVS down 3,77%?
Dive Deeper
ANVS:NYSE
Annovis Bio Inc
US$1,02
-3,77%
(-0,040) 1D
US$1,01
-0,98% (-0,0100)
After hours
Closed: 14 ຕ.ລ., 16 ໂມງ 0 ນາທີ 05 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANVS...
Open
US$1,05
High
US$1,08
Low
US$1,01
Mkt. cap
43,53 ລ້ານ
Avg. vol.
1,20 ລ້ານ
Volume
0,00
52-wk high
US$5,50
52-wk low
US$1,01
EPS
US$-1,78
Beta
1,23
Shares outstanding
42,68 ລ້ານ
No. of employees
8
Open
US$1,05
High
US$1,08
Low
US$1,01
Mkt. cap
43,53 ລ້ານ
Avg. vol.
1,20 ລ້ານ
Volume
0,00
52-wk high
US$5,50
52-wk low
US$1,01
EPS
US$-1,78
Beta
1,23
Shares outstanding
42,68 ລ້ານ
No. of employees
8
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
27 ນາທີກ່ອນ
Why Pegasystems Fell Even As Sales Rose
Benzinga
Benzinga
·
33 ນາທີກ່ອນ
RedCloud Holdings Shares Rise 18.40% After Hours - RedCloud Holdings (NASDAQ:RCT)
Stocktwits
Stocktwits
·
4 ຊົ່ວໂມງກ່ອນ
SKHY Tracks Worst Month Since Nasdaq Debut: SK Hynix Reportedly Wants To Ship More Chip Tools To China Before Building In US
Investor's Business Daily
Investor's Business Daily
·
4 ຊົ່ວໂມງກ່ອນ
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, ເພນຊີນວາເນຍ, ສະຫະລັດ
SectorBiotechnology
Websiteannovisbio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ANVS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANVS in the last 3 months.
Highest
Current US$1,02
US$17,00 (+1.566,67%)
Average
US$10,67 (+946,08%)
Lowest
US$7,00 (+586,27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
US$7,00
+586,3%
09/04/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
US$17,00
+1.566,7%
08/18/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$8,00
+684,3%
08/17/2026
Unknown Analyst
Roth MKM
Buy
Initiated
US$8,00
+684,3%
07/07/2026
Last report
14 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$-0,40 / US$-0,46
+13,04%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6,29 ລ້ານ
8,75 ລ້ານ
16,72 ລ້ານ
12,01 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,14 ລ້ານ
955,15 ພັນ
1,19 ລ້ານ
2,37 ລ້ານ
Operating expense
7,43 ລ້ານ
9,71 ລ້ານ
17,91 ລ້ານ
14,38 ລ້ານ
Total operating expenses
7,43 ລ້ານ
9,71 ລ້ານ
17,91 ລ້ານ
14,38 ລ້ານ
Operating income
-7,43 ລ້ານ
-9,71 ລ້ານ
-17,91 ລ້ານ
-14,38 ລ້ານ
Other non operating income
20,00 ພັນ
-296,00 ພັນ
268,00 ພັນ
-603,34 ພັນ
EBT including unusual items
-7,26 ລ້ານ
-9,83 ລ້ານ
-17,61 ລ້ານ
-14,82 ລ້ານ
EBT excluding unusual items
-7,26 ລ້ານ
-9,83 ລ້ານ
-17,51 ລ້ານ
-14,82 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,26 ລ້ານ
-9,83 ລ້ານ
-17,61 ລ້ານ
-14,82 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,37
-0,39
-0,63
-0,40
Interest and investment income
152,32 ພັນ
167,74 ພັນ
137,80 ພັນ
160,23 ພັນ
Interest expense
-
-
-
-
Net interest expenses
152,32 ພັນ
167,74 ພັນ
137,80 ພັນ
160,23 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google